New oral GLP-1 formslike drops and lozengesshow promising results, though injectable GLP-1s still have the most clinical data for significant weight loss
[1] [5] Patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should discuss these conditions with their healthcare provider, as GLP-1 receptor agonists have been associated with thyroid C-cell tumours in animal studies
However, Mounjaro is specifically approved for managing type 2 diabetes, while Zepbound is approved for chronic weight management in adults with obesity or weight-related conditions such as high blood pressure or type 2 diabetes
MHRA/GOV.UK: First GLP-1 tablet for weight loss approved in the UK
The pyridoxine in your compound may contribute positively to this marker
Six years ago, I decided to switch from a reactive to a proactive style of care and open my metabolic-health practice